Aklilu, M <br/><br/>
Phase II study of flavopiridol in patients with advanced colorectal cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Aug 2003 
 - 1270-3 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdg343  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Colorectal Neoplasms--drug therapy<br/>Confidence Intervals<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Flavonoids--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Infusions, Intravenous<br/>Magnetic Resonance Imaging<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neoplasm Invasiveness--pathology<br/>Neoplasm Staging<br/>Piperidines--administration & dosage<br/>Probability<br/>Survival Analysis<br/>Tomography, X-Ray Computed<br/>Treatment Outcome